Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by Hechanova GroupEditha Hechanova of Hechanova Group overviews the Philippines’ recent overhaul of its trademark regulations, with significant repercussions for foreign applicants -
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Suvarna Pandey of RNA Technology and IP Attorneys analyse the fiery ruling which declared ‘an order which contains reasons that no one can understand is worse than an unreasoned order’
-
Sponsored by Hanol IP & LawAt an exciting time in South Korea’s IP evolution, Min Son of Hanol IP & Law reports on the jurisdiction’s new user-friendly trademark measures.
-
Sponsored by Gün and PartnersGüldeniz Doğan Alkan and Cansu Evren of Gün + Partners say that a recent ruling raises the question of how many trademarks should be imitated for an act of bad faith to be recognised
-
Sponsored by ZaccoThere are several benefits to companies opting for a hybrid approach to IP rights management using a service provider, say experts from Zacco in their second article of a four-part series exploring some of the issues that are frequently raised by companies
-
Sponsored by ABE & PartnersTakanori Abe of Abe & Partners presents a personal account of his experience regarding presentations in court in Japan, the US, Germany, and the UK, and suggests cultural factors may explain the different approaches
